Qsam Biosciences Valuation
| QSAMDelisted Stock | USD 4.49 0.05 1.13% |
At this time, the company appears to be overvalued. Qsam Biosciences holds a recent Real Value of $4.11 per share. The prevailing price of the company is $4.49. Our model determines the value of Qsam Biosciences from analyzing the company fundamentals such as Price To Book of 201.64 X, shares outstanding of 4.45 M, and Return On Equity of -33.77 as well as examining its technical indicators and probability of bankruptcy. . In general, most investors support obtaining undervalued entities and abandoning overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Qsam Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Qsam Biosciences is based on 3 months time horizon. Increasing Qsam Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Qsam otc stock is determined by what a typical buyer is willing to pay for full or partial control of Qsam Biosciences. Since Qsam Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Qsam OTC Stock. However, Qsam Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.49 | Real 4.11 | Hype 4.49 | Naive 4.6 |
The intrinsic value of Qsam Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Qsam Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Qsam Biosciences helps investors to forecast how Qsam otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Qsam Biosciences more accurately as focusing exclusively on Qsam Biosciences' fundamentals will not take into account other important factors: Qsam Biosciences Total Value Analysis
Qsam Biosciences is at this time forecasted to have valuation of 36.03 M with market capitalization of 73.79 B, debt of 7.5 K, and cash on hands of 429.35 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Qsam Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
36.03 M | 73.79 B | 7.5 K | 429.35 K |
Qsam Biosciences Asset Utilization
One of the ways to look at asset utilization of Qsam is to check how much profit was generated for every dollar of assets it reports. Qsam Biosciences holds a negative application of assets of -2.38 pct., losing $0.0238 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Qsam Biosciences shows how discouraging it operates for each dollar spent on its assets.Qsam Biosciences Ownership Allocation
The market capitalization of Qsam Biosciences is $73.79 Billion. Qsam Biosciences has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Qsam Biosciences Profitability Analysis
Net Loss for the year was (4.39 M) with profit before overhead, payroll, taxes, and interest of 916.67 K.About Qsam Biosciences Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Qsam Biosciences. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Qsam Biosciences based exclusively on its fundamental and basic technical indicators. By analyzing Qsam Biosciences's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Qsam Biosciences's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Qsam Biosciences. We calculate exposure to Qsam Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Qsam Biosciences's related companies.QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas. Qsam Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
8 Steps to conduct Qsam Biosciences' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Qsam Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Qsam Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Qsam Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Qsam Biosciences' revenue streams: Identify Qsam Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Qsam Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Qsam Biosciences' growth potential: Evaluate Qsam Biosciences' management, business model, and growth potential.
- Determine Qsam Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Qsam Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Qsam Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Qsam Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 3 M | |
| Shares Float | 2.1 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Qsam OTC Stock
If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |